Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Radiation Oncology/Therapy: Page 281
Blondel to leave IBt
By
AuntMinnie.com staff writers
Radiotherapy and radioisotope developer Eckert & Ziegler Isotope Products has announced that the CEO of its IBt Bebig subsidiary, François Blondel, is leaving the company.
March 23, 2010
Accuray goes direct in India
By
AuntMinnie.com staff writers
Radiotherapy firm Accuray has set up a sales, marketing, and service force to handle the company's products in India.
March 23, 2010
Maryland hits Johns Hopkins with $370K fine
By
Cynthia E. Keen
The state of Maryland has fined Johns Hopkins University $370,000 as part of a settlement regarding alleged violations of state law relating to the university's use of ionizing radiation and its handling of radioactive materials for medical and research purposes.
March 23, 2010
NRC hits Philadelphia VA with $227,500 fine
March 16, 2010
NRC hits Philadelphia VA with $227,500 fine
By
Cynthia E. Keen
The U.S. Nuclear Regulatory Commission (NRC) has proposed a $227,500 fine against the U.S. Department of Veterans Affairs (VA) for violations of NRC regulations associated with errors in the prostate brachytherapy program at the VA hospital in Philadelphia.
March 16, 2010
Calypso wraps up first U.K. install
By
AuntMinnie.com staff writers
Electromagnetic localization developer Calypso Medical Technologies has installed its Calypso system at the Royal Marsden Hospital in London, U.K.
March 16, 2010
RaySearch gets FDA nod
By
AuntMinnie.com staff writers
Swedish radiation therapy firm RaySearch has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RayStation treatment planning system.
March 16, 2010
SenoRx CEO passes away
By
AuntMinnie.com staff writers
Lloyd Malchow, chairman and CEO of breast brachytherapy developer SenoRx, died March 14.
March 16, 2010
SBRT improves control in inoperable lung cancer patients
By
Cynthia E. Keen
Stereotactic body radiation therapy (SBRT) is effective in controlling the primary tumor of nearly 100% of patients with medically inoperable early-stage non-small cell lung cancer who are still alive three years after treatment, according to early findings of a clinical trial published today in the
Journal of the American Medical Association
.
March 15, 2010
Orbital Therapy finishes prototype
By
AuntMinnie.com staff writers
Breast cancer treatment products developer Orbital Therapy said it has built a proof-of-concept prototype for breast cancer irradiation, demonstrating the feasibility of operating an external-beam radiotherapy device without the use of a shielded bunker infrastructure.
March 15, 2010
Elekta posts 9% sales gain
By
AuntMinnie.com staff writers
Swedish oncology firm Elekta achieved a 9% gain in net sales for the first nine months of fiscal year 2010.
March 14, 2010
Varian to fill U.K. Clinac order
By
AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems has received an order for two Clinac iX accelerators with RapidArc capability from the Kent Oncology Centre in the U.K.
March 11, 2010
Previous Page
Page 281 of 468
Next Page